2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 COA of Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.
Donthiboina, Kavitha;Anchi, Pratibha;Gurram, Sowmyasree;Sai Mani, Geeta;Lakshmi Uppu, Jaya;Godugu, Chandraiah;Shankaraiah, Nagula;Kamal, Ahmed published 《Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors》 in 2020. The article was appeared in 《Bioorganic Chemistry》. They have made some progress in their research.COA of Formula: C13H11N3 The article mentions the following:
A new series of N-(2-(1H-benzo[d]imidazol-2-yl)phenyl) cinnamides I [R = H, 4-CH3, 4-F, etc.; R1 = H, 4-NO2, 4-Br, etc.] was prepared and evaluated for their in-vitro cytotoxic activity using various cancer cell lines viz.A549 (human non-small cell lung cancer), MDA-MB-231 (human triple neg. breast cancer), B16-F10 (mouse melanoma), BT-474 (human breast cancer), and 4 T1 (mouse triple neg. breast cancer). In the series of tested compounds, I [R = 4-CH3 ; R1 = 4-OC2H5] showed potent cytotoxic activity against non-small cell lung cancer cell line with IC50 value of 0.29 ± 0.02μM. The cytotoxicity of most potent compound I [R = 4-CH3 ; R1 = 4-OC2H5] was also tested on NRK-52E (normal rat kidney epithelial cell line) and showed less cytotoxicity compared to cancer cells. Tubulin polymerization assay indicated that the I [R = 4-CH3 ; R1 = 4-OC2H5] was able to impede the cell division by inhibiting tubulin polymerization Moreover, mol. docking study also suggested the binding of I [R = 4-CH3 ; R1 = 4-OC2H5] at the colchicine-binding site of the tubulin protein. Cell cycle anal. revealed that the I [R = 4-CH3 ; R1 = 4-OC2H5] arrests G2/M phase. In addition, I [R = 4-CH3 ; R1 = 4-OC2H5] induced apoptosis in A549 cell lines was evaluated by various staining studies like acridine orange, DAPI, anal. of mitochondrial membrane potential, annexin V-FITC, and DCFDA assays. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .
2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 COA of Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.
Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem